Why is the use of Digitalis Withering? Another Reason that we Need Medical Heart Failure Specialists
Author:
- 19 October 2017
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 20 (5) , 851-852
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Declining Risk of Sudden Death in Heart FailureNew England Journal of Medicine, 2017
- Dose Response Characterization of the Association of Serum Digoxin Concentration with Mortality Outcomes in the Digitalis Investigation Group TrialEuropean Journal of Heart Failure, 2016
- Targeting Digoxin Dosing to Serum Concentration: Is the Bullseye Too Small?European Journal of Heart Failure, 2016
- 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart FailureEuropean Journal of Heart Failure, 2016
- Temporal Trends of Digoxin Use in Patients Hospitalized With Heart FailureJACC: Heart Failure, 2016
- Unbelievable Folly of Clinical Trials in Heart FailureCirculation: Heart Failure, 2016
- Digoxin Use and Lower 30-day All-cause Readmission for Medicare Beneficiaries Hospitalized for Heart FailureThe American Journal of Medicine, 2014
- Effectiveness and Safety of Digoxin Among Contemporary Adults With Incident Systolic Heart FailureCirculation: Cardiovascular Quality and Outcomes, 2013
- Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart FailureNew England Journal of Medicine, 2002
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997